James B. Delehanty

Controlled actuation of therapeutic nanoparticles: moving beyond passive delivery modalities.

Monoclonal antibodies that recognize minimal differences in the three-dimensional structures of metal-chelate complexes.

A microarray immunoassay for simultaneous detection of proteins and bacteria.

Allosteric binding properties of a monoclonal antibody and its Fab fragment.

Method for printing functional protein microarrays.

Identification of important residues in metal-chelate recognition by monoclonal antibodies.

Printing functional protein microarrays using piezoelectric capillaries.

Carboxylic acid functionalized cobalt(III) cyclen complexes for catalytic hydrolysis of phosphodiester bonds.

A comparison of microscope slide substrates for use in transfected cell microarrays.

Transfected cell microarrays for the expression of membrane-displayed single-chain antibodies.

RNA hydrolysis and inhibition of translation by a Co(III)-cyclen complex.

Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery.

Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library.

Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library.

Binding and neutralization of lipopolysaccharides by plant proanthocyanidins.

Enhancing the stability and biological functionalities of quantum dots via compact multifunctional ligands.

Antiviral properties of cobalt(III)-complexes.

Immobilized proanthocyanidins for the capture of bacterial lipopolysaccharides.

Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides.

Delivering quantum dots into cells: strategies, progress and remaining issues.

Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery.

Combining chemoselective ligation with polyhistidine-driven self-assembly for the modular display of biomolecules on quantum dots.

Intracellular bioconjugation of targeted proteins with semiconductor quantum dots.

Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system.

Multidentate poly(ethylene glycol) ligands provide colloidal stability to semiconductor and metallic nanocrystals in extreme conditions.

Quantum-dot/dopamine bioconjugates function as redox coupled assemblies for in vitro and intracellular pH sensing.

Transfected cell microarrays for the expression of membrane-displayed single-chain antibodies.

Multifunctional compact zwitterionic ligands for preparing robust biocompatible semiconductor quantum dots and gold nanoparticles.

Spatiotemporal multicolor labeling of individual cells using peptide-functionalized quantum dots and mixed delivery techniques.

Reactive semiconductor nanocrystals for chemoselective biolabeling and multiplexed analysis.

Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.

Semiconductor quantum dots in bioanalysis: crossing the valley of death.

Quantum dots and fluorescent protein FRET-based biosensors.

Elaborate nanoparticle-based traps for catching cytosolic players in the act.

Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery.

Nanoparticle targeting to neurons in a rat hippocampal slice culture model.

Active cellular sensing with quantum dots: transitioning from research tool to reality; a review.

Quantitative LSPR imaging for biosensing with single nanostructure resolution.

Optimizing protein coordination to quantum dots with designer peptidyl linkers.

Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials.

Evaluation of diverse peptidyl motifs for cellular delivery of semiconductor quantum dots.

Site-specific cellular delivery of quantum dots with chemoselectively-assembled modular peptides.

Cytotoxicity of quantum dots used for in vitro cellular labeling: role of QD surface ligand, delivery modality, cell type, and direct comparison to organic fluorophores.

Quantitative imaging of protein secretions from single cells in real time.

Controlling the actuation of therapeutic nanomaterials: enabling nanoparticle-mediated drug delivery.

Multifunctional liquid crystal nanoparticles for intracellular fluorescent imaging and drug delivery.

Continuing progress toward controlled intracellular delivery of semiconductor quantum dots.

In vitro interaction of colloidal nanoparticles with mammalian cells: What have we learned thus far?

Quantum dot-based multiphoton fluorescent pipettes for targeted neuronal electrophysiology.

Delivery and tracking of quantum dot peptide bioconjugates in an intact developing avian brain.

Peptides for specifically targeting nanoparticles to cellular organelles: quo vadis?

The Role of Negative Charge in the Delivery of Quantum Dots to Neurons.

Electric Field Modulation of Semiconductor Quantum Dot Photoluminescence: Insights Into the Design of Robust Voltage-Sensitive Cellular Imaging Probes.

Optimizing Nanoplasmonic Biosensor Sensitivity with Orientated Single Domain Antibodies.

Modulation of Intracellular Quantum Dot to Fluorescent Protein Förster Resonance Energy Transfer via Customized Ligands and Spatial Control of Donor-Acceptor Assembly.

Lipid Raft-Mediated Membrane Tethering and Delivery of Hydrophobic Cargos from Liquid Crystal-Based Nanocarriers.

Controlled actuation of therapeutic nanoparticles: an update on recent progress.

Emerging Physicochemical Phenomena along with New Opportunities at the Biomolecular-Nanoparticle Interface.

Energy Transfer with Semiconductor Quantum Dot Bioconjugates: A Versatile Platform for Biosensing, Energy Harvesting, and Other Developing Applications.

Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells.